Gregory Lee, MD
Ophthalmology · Cumming, GANPI 1609162155
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $144,777 of the $213,512 with a category attached, or 67.8%. 24 manufacturers reported payments, led by Genentech USA, Inc. at 35.0% of the total. 2025 is the largest year on record at $127,282, more than ten times the $8,952 reported in 2019. Among ophthalmology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 405 payments — averaging $527.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$75K
- Apellis Pharmaceuticals, Inc.$58K
- Regeneron Healthcare Solutions, Inc.$32K
- Astellas Pharma US Inc$31K
- Alimera Sciences, Inc.$6K
- Alcon$3K
- plus $8K from 18 others
Across 12 payments — averaging $40.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$480
What the payments were for
- Consulting fees$31,90515%
- Speaking & faculty fees$144,77768%
- Travel & lodging$19,3679%
- Food & beverage$17,4638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 120 | $74,789 |
| Apellis Pharmaceuticals, Inc. | 48 | $58,205 |
| Regeneron Healthcare Solutions, Inc. | 65 | $31,646 |
| Astellas Pharma US Inc | 30 | $31,387 |
| Alimera Sciences, Inc. | 30 | $6,019 |
| Alcon | 29 | $3,252 |
| Genentech, Inc. | 3 | $2,501 |
| Ocular Therapeutix, Inc. | 1 | $1,500 |
| AbbVie(2 entities) | 27 | $1,108 |
| Novartis | 21 | $1,016 |
| ANI Pharmaceuticals, Inc. | 10 | $632 |
| Regeneron | 2 | $255 |
| Dutch Ophthalmic, USA | 3 | $253 |
| Bausch & Lomb Americas Inc. | 3 | $193 |
| Sight Sciences, Inc. | 1 | $147 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| Spark Therapeutics, Inc. | 1 | $119 |
| Biogen | 1 | $112 |
| Carl Zeiss Meditec, Inc. | 1 | $70 |
| Notal Vision, Inc. | 1 | $60 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $36 |
| Eyepoint US, Inc. | 2 | $31 |
| Coherus Oncology, Inc. | 2 | $30 |
| Sandoz | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$213,512 in reported general payments places this provider in the 95th percentile of 481 ophthalmology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 233 | $11,382 |
| Bromfenac Sodium | 31 | $3,160 |
| MoxifloxacinMoxifloxacin Hcl | 161 | $2,925 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 123 | $2,039 |
| Brimonidine Tartrate | 34 | $1,403 |
| Latanoprost | 50 | $354 |
| Timolol Maleate | 33 | $239 |
| Dorzolamide Hcl | 18 | $185 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Cumming
- Niraj DesaiCumming$129K
- Byron CookCumming$29K
- Matthew KaufmanCumming$14K
- Gagan SawhneyAtlanta$582K
- Lawrence WoodardAtlanta$578K
- Stephanie VanderveldtAtlanta$384K
- Steven YehAtlanta$289K
- Jack ChapmanGainesville$244K
- Puneet PandaMarietta$185K
- Jeffrey TranSuwanee$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.